Company Filing History:
Years Active: 2006
Title: Simone Hornemann: Innovator in Vaccinia Virus Research
Introduction
Simone Hornemann is a distinguished inventor based in Munich, Germany. She has made significant contributions to the field of virology, particularly in the development of mutant vaccinia viruses. Her innovative work has implications for the generation of recombinant viruses, which are crucial for various applications in medical research.
Latest Patents
Hornemann holds a patent for "Vaccinia virus MVA-E3L-knockout-mutants and use thereof." This invention relates to mutant MVA vaccinia viruses that are utilized for generating recombinant MVA viruses. The patent also covers host cells infected with these mutant MVA viruses, DNA-vector constructs, and methods for generating recombinant MVA using these components. The mutant MVA vaccinia viruses are characterized by the inactivation of the MVA ORF 050L gene or a functional part thereof in the viral genome.
Career Highlights
Simone Hornemann is affiliated with the GSF-Forschungszentrum für Umwelt und Gesundheit, GmbH, where she conducts her research. Her work has been pivotal in advancing the understanding of vaccinia viruses and their potential applications in therapeutics and vaccines.
Collaborations
Hornemann collaborates with notable colleagues in her field, including Volker Erfle and Gerd Sutter. These partnerships enhance the research efforts and contribute to the innovative outcomes in their projects.
Conclusion
Simone Hornemann's contributions to the field of virology, particularly through her patent on mutant vaccinia viruses, highlight her role as a leading inventor in this area. Her work continues to pave the way for advancements in medical research and therapeutic applications.